These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1. Pizzuto S; Duffey G; Weant J; Eveleth D J Vis Exp; 2022 Jul; (185):. PubMed ID: 35938798 [TBL] [Abstract][Full Text] [Related]
28. What does the future hold for the treatment of Fuchs endothelial dystrophy; will 'keratoplasty' still be a valid procedure? Bruinsma M; Tong CM; Melles GR Eye (Lond); 2013 Oct; 27(10):1115-22. PubMed ID: 23846374 [TBL] [Abstract][Full Text] [Related]
29. [Morphological features of the cornea in eyes with pseudophakic bullous keratopathy and Fuchs endothelial corneal dystrophy]. Fisenko NV; Trufanov SV; Demura TA Vestn Oftalmol; 2022; 138(1):31-37. PubMed ID: 35234418 [TBL] [Abstract][Full Text] [Related]
30. Descemet's membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Price MO; Giebel AW; Fairchild KM; Price FW Ophthalmology; 2009 Dec; 116(12):2361-8. PubMed ID: 19875170 [TBL] [Abstract][Full Text] [Related]
31. Role of descemet's stripping without keratoplasty in management of endothelial disease. Northey LC; Moloney G Curr Opin Ophthalmol; 2023 Jul; 34(4):348-353. PubMed ID: 37254864 [TBL] [Abstract][Full Text] [Related]
32. Increased Corneal Endothelial Cell Migration in Fuchs Endothelial Corneal Dystrophy: A Live Cell Imaging Study. Ong Tone S; Wylegala A; Böhm M; Melangath G; Deshpande N; Jurkunas UV Ophthalmol Sci; 2021 Mar; 1(1):100006. PubMed ID: 36246012 [TBL] [Abstract][Full Text] [Related]
33. Diseases of the corneal endothelium. Jeang LJ; Margo CE; Espana EM Exp Eye Res; 2021 Apr; 205():108495. PubMed ID: 33596440 [TBL] [Abstract][Full Text] [Related]
34. Sustained Activation of the Unfolded Protein Response Induces Cell Death in Fuchs' Endothelial Corneal Dystrophy. Okumura N; Kitahara M; Okuda H; Hashimoto K; Ueda E; Nakahara M; Kinoshita S; Young RD; Quantock AJ; Tourtas T; Schlötzer-Schrehardt U; Kruse F; Koizumi N Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3697-3707. PubMed ID: 28727885 [TBL] [Abstract][Full Text] [Related]
35. Cell derived matrices from bovine corneal endothelial cells as a model to study cellular dysfunction. Jalilian I; Muppala S; Ali M; Anderson JD; Phinney B; Salemi M; Wilmarth PA; Murphy CJ; Thomasy SM; Raghunathan V Exp Eye Res; 2023 Jan; 226():109303. PubMed ID: 36343671 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of Visual Quality in Patients With Fuchs Endothelial Corneal Dystrophy. Oie Y; Watanabe S; Nishida K Cornea; 2016 Nov; 35 Suppl 1():S55-S58. PubMed ID: 27631348 [TBL] [Abstract][Full Text] [Related]
37. Nanotopography by chromatic confocal microscopy of the endothelium in Fuchs endothelial corneal dystrophy, pseudophakic bullous keratopathy and healthy corneas. Vaitinadapoulé H; Poinard S; He Z; Pascale-Hamri A; Thomas J; Gain P; Thuret JY; Mascarelli F; Thuret G; Br J Ophthalmol; 2024 Jul; 108(8):1184-1192. PubMed ID: 37714683 [TBL] [Abstract][Full Text] [Related]
38. The pathophysiology of Fuchs' endothelial dystrophy--a review of molecular and cellular insights. Zhang J; Patel DV Exp Eye Res; 2015 Jan; 130():97-105. PubMed ID: 25446318 [TBL] [Abstract][Full Text] [Related]
39. Ex vivo excimer laser ablation of cornea guttata and ROCK inhibitor-aided endothelial recolonization of ablated central cornea. Kassumeh S; von Studnitz A; Priglinger SG; Fuchshofer R; Luft N; Moloney G; Dirisamer M; Ohlmann A Acta Ophthalmol; 2020 Sep; 98(6):e773-e780. PubMed ID: 32017400 [TBL] [Abstract][Full Text] [Related]